Global Self Expanding Metal Stent Market Size By Type (Fully, Partially), By Application (Hospital, Industrial Vacuum Cleaning), By Region, And Segment Forecasts, 2023 to 2032

The Global Self-Expanding Metal Stent Market was valued at USD 5.6 billion in 2023 and is projected to reach USD 9.3 billion by 2031, growing at a CAGR of 6.5% during the forecast period of 2023 to 2031. The increasing incidence of cardiovascular and gastrointestinal diseases, coupled with advancements in minimally invasive surgical techniques, is significantly contributing to market growth. Self-expanding metal stents are widely used in procedures such as peripheral artery disease (PAD), biliary strictures, and esophageal obstructions, where they offer flexibility, sustained patency, and enhanced procedural success.

Drivers:

1. Rising Prevalence of Chronic Diseases:

An increase in lifestyle-related diseases, particularly cardiovascular and gastrointestinal disorders, is driving demand for minimally invasive interventions using self-expanding metal stents.

2. Technological Innovations in Stent Design:

Manufacturers are investing in bioresorbable coatings, drug-eluting technologies, and radiopaque materials to enhance stent visibility and therapeutic efficacy.

3. Aging Population and Increased Healthcare Access:

The global rise in elderly demographics, especially in developed and emerging economies, is creating a broader patient base for stent-based procedures.

Restraints:

1. Risk of Complications and Stent Migration:

Although rare, stent-related complications such as restenosis, thrombosis, or device migration can limit wider adoption in certain clinical scenarios.

2. High Costs of Advanced Stent Systems:

The high price of drug-eluting and next-generation self-expanding metal stents may pose affordability challenges in cost-sensitive markets.

Opportunity:

1. Growth in Emerging Healthcare Markets:

Countries in Asia-Pacific and Latin America are witnessing a surge in interventional procedures, creating opportunities for market expansion due to improved healthcare infrastructure and increasing government investments.

2. Rising Use in Non-Vascular Applications:

Self-expanding metal stents are being increasingly utilized in non-vascular domains, such as biliary, esophageal, and colorectal treatments, expanding their clinical utility and market potential.

Market by System Type Insights:

By system type, Drug-Eluting Self-Expanding Metal Stents accounted for the largest market share in 2023. These stents offer the advantage of reducing restenosis rates by releasing therapeutic agents, making them particularly effective in cardiovascular applications. The Bare-Metal Stent segment, while declining in dominance, remains relevant in select cases due to its lower cost and simpler implantation protocols.

Market by End-use Insights:

Hospitals remained the dominant end-use segment in 2023, accounting for over 60% of total revenue. This is attributed to the availability of skilled interventional radiologists and cardiologists, advanced imaging equipment, and reimbursement support. The Ambulatory Surgical Centers (ASCs) segment is expected to register the fastest growth, driven by shorter recovery times and lower procedural costs.

Market by Regional Insights:

North America led the global market in 2023, supported by strong healthcare infrastructure, high procedure volumes, and active R&D activities. However, Asia-Pacific is poised to exhibit the highest CAGR through 2031 due to increasing adoption of interventional procedures, rising healthcare awareness, and the expansion of public and private healthcare facilities.

Competitive Scenario:

Key players in the Global Self-Expanding Metal Stent Market include Boston Scientific Corporation, Medtronic plc, Cook Medical, Abbott Laboratories, Terumo Corporation, BIOTRONIK SE & Co. KG, Micro-Tech (Nanjing) Co., Ltd., Becton, Dickinson and Company, and Merit Medical Systems, Inc. These firms are emphasizing product launches, strategic acquisitions, and collaborations to expand their global footprint.

Recent Developments Include:

In 2023, Boston Scientific received FDA approval for a next-generation drug-eluting self-expanding stent for peripheral artery disease.

Medtronic launched a customizable metal stent platform aimed at complex gastrointestinal strictures in 2024.

In 2025, Cook Medical expanded its Asia-Pacific operations with a new manufacturing unit focused on advanced stent technologies.

Scope of Work – Global Self-Expanding Metal Stent Market

Report Metric Details

Market Size (2023) USD 5.6 billion

Projected Market Size (2031) USD 9.3 billion

CAGR (2023-2031) 6.5%

Market Segments By System Type (Drug-Eluting, Bare-Metal), By End-use (Hospitals, ASCs)

Growth Drivers Chronic disease prevalence, aging population, stent innovation

Opportunities Emerging markets, expanded use in non-vascular procedures

Key Market Developments:

2023: Boston Scientific launched a new generation of flexible, drug-eluting self-expanding stents with improved biocompatibility.

2024: Terumo Corporation entered into a partnership with AI-driven imaging firms to enhance stent placement accuracy.

2025: Abbott Laboratories introduced a hybrid stent with polymer coatings tailored for esophageal strictures.

FAQs:

1) What is the current market size of the Global Self-Expanding Metal Stent Market?

The market was valued at USD 5.6 billion in 2023.

2) What is the major growth driver of the Global Self-Expanding Metal Stent Market?

Key drivers include the rising prevalence of cardiovascular diseases and advancements in minimally invasive surgical technologies.

3) Which is the largest region during the forecast period in the Global Self-Expanding Metal Stent Market?

North America held the largest share in 2023, but Asia-Pacific is expected to grow at the fastest rate through 2031.

4) Which segment accounted for the largest market share in the Global Self-Expanding Metal Stent Market?

The Drug-Eluting Stent segment led the market in terms of system type in 2023.

5) Who are the key market players in the Global Self-Expanding Metal Stent Market?

Boston Scientific, Medtronic, Abbott, Cook Medical, and BIOTRONIK are among the key players.